Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295713.RAwPTBVFx0Rf8Xzxz05AFFGwgfLWGlNOWfevvbD0-470U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295713.RAwPTBVFx0Rf8Xzxz05AFFGwgfLWGlNOWfevvbD0-470U130_assertion type Assertion NP1295713.RAwPTBVFx0Rf8Xzxz05AFFGwgfLWGlNOWfevvbD0-470U130_head.
- NP1295713.RAwPTBVFx0Rf8Xzxz05AFFGwgfLWGlNOWfevvbD0-470U130_assertion description "[The median age of the patients was 62 years, and patients had received a median of three previous therapies for CLL; 31% had chromosome 17p13.1 deletion, and 75% had unmutated immunoglobulin heavy-chain variable genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295713.RAwPTBVFx0Rf8Xzxz05AFFGwgfLWGlNOWfevvbD0-470U130_provenance.
- NP1295713.RAwPTBVFx0Rf8Xzxz05AFFGwgfLWGlNOWfevvbD0-470U130_assertion evidence source_evidence_literature NP1295713.RAwPTBVFx0Rf8Xzxz05AFFGwgfLWGlNOWfevvbD0-470U130_provenance.
- NP1295713.RAwPTBVFx0Rf8Xzxz05AFFGwgfLWGlNOWfevvbD0-470U130_assertion SIO_000772 26641137 NP1295713.RAwPTBVFx0Rf8Xzxz05AFFGwgfLWGlNOWfevvbD0-470U130_provenance.
- NP1295713.RAwPTBVFx0Rf8Xzxz05AFFGwgfLWGlNOWfevvbD0-470U130_assertion wasDerivedFrom befree-2016 NP1295713.RAwPTBVFx0Rf8Xzxz05AFFGwgfLWGlNOWfevvbD0-470U130_provenance.
- NP1295713.RAwPTBVFx0Rf8Xzxz05AFFGwgfLWGlNOWfevvbD0-470U130_assertion wasGeneratedBy ECO_0000203 NP1295713.RAwPTBVFx0Rf8Xzxz05AFFGwgfLWGlNOWfevvbD0-470U130_provenance.